TABLE 1.

Clinical characteristics of MG patients included in the study.

Age (median)	29 years
Sex	39 (89%)	Female
	5 (11%)	Male
Antibody status	40 (91)	Anti-AChR positive
	4 (9%)	Seronegative
	1 (2%)	Anti-MuSK positive
Therapy at time of analysis	43 (98%)	Acetylcholinesterase inhibitors
	2 (5%)	Plus corticosteroids
	1 (2%)	Plus immunosuppression
MG clinical subtype	31 (70%)	Generalized MG
	12 (27%)	Ocular MG
	1 (2%)	Not defined
Thymectomy	41 (93%)	Yes
	3 (7%)	No
Thymic histology	31 (70%)	Hyperplasia
	1 (2%)	Thymoma
	7 (18%)	No abnormality detected
	2 (5%)	Not known